Citations 2
P1083: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2
Poon, Michelle, Champion, Rebecca A., Guidez, Stéphanie , Alonso, Aránzazu Alonso, Jagadeesh, Deepa, Tucker, David , Cai, Jingxian, Oliveira, Carolina Leite De, Chaudhry, Aafia, Ambati, Srikanth, Taszner, Michał , Luminari, Stefano , Cho, Seok‐Goo , Novelli, Silvana , Gouill, Steven Le , Villasboas, José C. , Champion, Rebecca, Bachy, Emmanuel , Alonso, Aránzazu , Jagadeesh, Deepa , Merli, Michele , Zhu, Min , Mohamed, Hesham , Kim, Tae Min
HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e214536e
Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Grade 1-3a: Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2
Novelli, Silvana , Poon, Michelle, Champion, Rebecca A., Guidez, Stéphanie , Alonso, Aránzazu Alonso, Jagadeesh, Deepa, Cai, Jingxian, Oliveira, Carolina Leite De, Zhu, Min , Chaudhry, Aafia, Ambati, Srikanth, Kim, Tae Min , Taszner, Michał , Cho, Seok‐Goo , Gouill, Steven Le , Villasboas, José C. , Champion, Rebecca, Bachy, Emmanuel , Alonso, Aránzazu , Jagadeesh, Deepa , Merli, Michele , Tucker, David , Mohamed, Hesham , Luminari, Stefano
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2280-2282